Glenview Trust’s Inotiv NOTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,000
Closed -$113 – 540
2026
Q2
$113 Hold
11,000
– – ﹤0.01% 517
2026
Q1
$3K Hold
11,000
– – ﹤0.01% 500
2025
Q4
$6.18K Sell
11,000
-3,350
-23% -$3.5K ﹤0.01% 491
2025
Q3
$20.8K Hold
14,350
– – ﹤0.01% 487
2025
Q2
$26.1K Hold
14,350
– – ﹤0.01% 504
2025
Q1
$31.7K Hold
14,350
– – ﹤0.01% 473
2024
Q4
$59.4K Hold
14,350
– – ﹤0.01% 477
2024
Q3
$24.4K Hold
14,350
– – ﹤0.01% 474
2024
Q2
$23.8K Hold
14,350
– – ﹤0.01% 463
2024
Q1
$157K Hold
14,350
– – ﹤0.01% 467
2023
Q4
$52.7K Buy
+14,350
New +$36.2K ﹤0.01% 464

Glenview Trust's NOTV Position: Q3 2026 in Review

Glenview Trust sold out of Inotiv (NOTV) in Q3 2026, closing a stake of 11,000 shares — an estimated $113 sold.

Glenview Trust first reported a position in NOTV in Q4 2023 and held it in 11 quarters. The position peaked at $157K in Q1 2024. 0 funds tracked by Wall St. Rank hold NOTV as of Q3 2026.

  • Glenview Trust reported no remaining Inotiv position as of Q3 2026 after selling out during the quarter.
  • Glenview Trust sold 11,000 Inotiv shares in Q3 2026, an estimated $113.
  • Glenview Trust first reported a position in Inotiv in Q4 2023 and held it in 11 quarters.
  • Glenview Trust's Inotiv position peaked at $157K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Inotiv as of Q3 2026.

Based on Glenview Trust's 13F filing for Q3 2026, filed 28 Oct 2026.